Latest News

FDA Warns of Serious Adverse Effects for Using Levetiracetam and Clobazam in Epilepsy
FDA Warns of Serious Adverse Effects for Using Levetiracetam and Clobazam in Epilepsy

November 28th 2023

In a new announcement, the FDA warns patients to immediately seek out medical attention if unexplained rash, fever, or swollen lymph nodes develop when using the antiseizure medications levetiracetam and clobazam.

Considerations Amid the Ever-Changing Field of Alzheimer Disease
Considerations Amid the Ever-Changing Field of Alzheimer Disease

November 28th 2023

NeurologyLive® Clinician of the Month Spotlight: Patricia C. Dugan, MD
NeurologyLive® Clinician of the Month Spotlight: Patricia C. Dugan, MD

November 28th 2023

Patient Headache Questionnaire Leads to Greater Diagnosis Rates, Less Non-Specific Diagnoses in Children
Patient Headache Questionnaire Leads to Greater Diagnosis Rates, Less Non-Specific Diagnoses in Children

November 28th 2023

High Rates of Depression, Anxiety, and Sleep Disturbances Found in NMOSD
High Rates of Depression, Anxiety, and Sleep Disturbances Found in NMOSD

November 27th 2023

CTAD 2023
AANEM 2023
MSMilan 2023
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Eptinezumab’s Real-World Impact as Chronic Migraine Treatment: Amaal Starling, MD, FAHS, FAAN
Eptinezumab’s Real-World Impact as Chronic Migraine Treatment: Amaal Starling, MD, FAHS, FAAN

November 28th 2023

Considerations Amid the Ever-Changing Field of Alzheimer Disease
Considerations Amid the Ever-Changing Field of Alzheimer Disease

November 28th 2023

Understanding Donanemab’s Clinical Relevance for Patients With Alzheimer Disease: Alireza Atri, MD, PhD
Understanding Donanemab’s Clinical Relevance for Patients With Alzheimer Disease: Alireza Atri, MD, PhD

November 22nd 2023

Advancements and Updates to the Treatment Algorithm of Migraine: Emad Estemalik, MD
Advancements and Updates to the Treatment Algorithm of Migraine: Emad Estemalik, MD

November 19th 2023

Video Series
Video Interviews
Podcasts

Most Recent

© 2023 MJH Life Sciences

All rights reserved.